---
title: "Lonza Group Ltd (LONN) Gets a Buy from Bernstein"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/293811029.md"
description: "Bernstein analyst Justin Smith maintained a Buy rating on Lonza Group Ltd (LONN), with shares closing at CHF548.00. The stock holds a Strong Buy consensus with a price target of CHF690.50, implying 26% upside. Additionally, Goldman Sachs maintained a Buy rating on July 23 with a CHF680.00 target."
datetime: "2026-07-25T03:35:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/293811029.md)
  - [en](https://longbridge.com/en/news/293811029.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/293811029.md)
generator: "portal-rs"
---

# Lonza Group Ltd (LONN) Gets a Buy from Bernstein

In a report released yesterday, Justin Smith from Bernstein maintained a Buy rating on Lonza Group Ltd. The company’s shares closed yesterday at CHF548.00.

### Claim 55% Off TipRanks

-   Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
-   Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks

Smith covers the Healthcare sector, focusing on stocks such as AstraZeneca, GlaxoSmithKline, and Roche Holding AG. According to TipRanks, Smith has an average return of 9.9% and a 61.86% success rate on recommended stocks. 

Lonza Group Ltd has an analyst consensus of Strong Buy, with a price target consensus of CHF690.50, implying a 26.00% upside from current levels. In a report released on July 23, Goldman Sachs also maintained a Buy rating on the stock with a CHF680.00 price target.

### Related Stocks

- [LZAGY.US](https://longbridge.com/en/quote/LZAGY.US.md)
- [AB.US](https://longbridge.com/en/quote/AB.US.md)
- [AZN.US](https://longbridge.com/en/quote/AZN.US.md)
- [GSK.US](https://longbridge.com/en/quote/GSK.US.md)
- [GSK.UK](https://longbridge.com/en/quote/GSK.UK.md)
- [RHHBY.US](https://longbridge.com/en/quote/RHHBY.US.md)
- [GS.US](https://longbridge.com/en/quote/GS.US.md)
- [AZN.UK](https://longbridge.com/en/quote/AZN.UK.md)
- [GSK.WI.US](https://longbridge.com/en/quote/GSK.WI.US.md)
- [RHHVF.US](https://longbridge.com/en/quote/RHHVF.US.md)
- [W4VR.SG](https://longbridge.com/en/quote/W4VR.SG.md)

## Related News & Research

- [Iconovo enters strategic collaboration agreement with Lonza on spray-dried inhaled formulations](https://longbridge.com/en/news/296445004.md)
- [Lonza Group Ltd (LONN) Gets a Buy from Barclays](https://longbridge.com/en/news/290403921.md)
- [NowVertical Group reports Q2 results](https://longbridge.com/en/news/296314409.md)
- [Lowe’s Earns Buy Rating as Strong Earnings and Cash Generation Offset Lower-End Guidance](https://longbridge.com/en/news/296383656.md)
- [Analyst Reiterates Buy on Cogent Biosciences, Maintains $55 Price Target Amid Late-Stage Pipeline and Strong Cash Position](https://longbridge.com/en/news/296384188.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**